Home > Blog
Genomics is no longer the future of medicine—it is already here. Advances in next-generation sequencing (NGS) and bioinformatics have transformed how clinicians can diagnose and...
Genomics is no longer the future of medicine—it is already here. Advances in next-generation sequencing (NGS) and bioinformatics have transformed how clinicians can diagnose and...
From rare pediatric diseases to inherited cancer syndromes, the secrets hidden in our DNA are guiding treatment, prevention, and family planning like never before. Here’s...
So, how is rare cancer different from regular cancer? And why should there be separate awareness? September 30th is annual Rare Cancer Day for awareness,...
From Lab Bench to AI Algorithms: Why Traditional R&D Alone May Not Be Adequate for Biotech Growth Following Compass Bioinformatics’ major investment news, we explore...
Genomic Analysis Software: A Comprehensive Guide for Healthcare Facilities and Patients Imagine a spell-checker, but for DNA: compared to displaying a misspelt word, it detects...
Why Rare Disease Screening Matters Rare diseases are individually uncommon, yet collectively affect 300 millions of people worldwide [1]. For many families, the journey to...
It once took over 10 years and $3 billion to sequence a single human genome. Today, thanks to Next-Generation Sequencing, that same analysis can be...
“We Didn’t Know It Had a Name”: Recognizing Fragile X Syndrome in Real Life It often starts with subtle signs: a toddler who isn’t speaking...
From early recognition to genetic variants and the new international criteria Neurofibromatosis (NF) is the name for a group of related but distinct genetic disorders...
The Core Challenge Some of the largest challenges in connecting a patient’s health status to the genomic data at hand are due to the lack...
